Anavex Life Sciences (AVXL) 31-Week Data Shows Anavex 2-73 Continues to be Well Tolerated - FBR
Tweet Send to a Friend
FBR Capital analyst Christopher James reiterated an Outperform rating and $10 price target on Anavex Life Sciences (NASDAQ: AVXL) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
